s6y

ARTELO BIOSCIENCES, INC.

Ticker
ARTL
CIK
1621221
Industry
Pharmaceutical Preparations
Formerly
REACTIVE MEDICAL INC., KNIGHT KNOX DEVELOPMENT CORP.

Financials 56

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q/A Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Jun 30, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 56 financials filings

News 99

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 99 news filings

Ownership 124

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 124 ownership filings

Prospectus 65

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. S-3/A Registration statement for specified transactions by certain issuers
  4. S-3 Registration statement for specified transactions by certain issuers
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. RW Registration Withdrawal Request
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. S-1/A General form of registration statement for all companies including face-amount certificate companies
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 65 prospectus filings

Proxies 24

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. PRER14A Preliminary revised proxy soliciting materials
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 24 proxies filings

Other 98

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G/A
  3. ARS Annual report to security holders
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. SCHEDULE 13G
  7. UPLOAD Letter (PDF)
  8. EFFECT Notice of Effectiveness
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 98 other filings